RTO

4-(dipropylsulfamoyl)benzoic acid

Created:2022-12-06
Last modified:  2023-07-19

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count38
Chiral Atom Count0
Bond Count38
Aromatic Bond Count6
2D diagram of RTO

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle HydrogenToggle Labels

Chemical Component Summary

Name4-(dipropylsulfamoyl)benzoic acid
Systematic Name (OpenEye OEToolkits)4-(dipropylsulfamoyl)benzoic acid
FormulaC13 H19 N O4 S
Molecular Weight285.359
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385CCCN(CCC)[S](=O)(=O)c1ccc(cc1)C(O)=O
SMILESOpenEye OEToolkits3.1.0.0CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O
Canonical SMILESCACTVS3.385 CCCN(CCC)[S](=O)(=O)c1ccc(cc1)C(O)=O
Canonical SMILESOpenEye OEToolkits3.1.0.0 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O
InChIInChI1.06 InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)
InChIKeyInChI1.06 DBABZHXKTCFAPX-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB01032 
NameProbenecid
Groups
  • approved
  • investigational
DescriptionThe prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
Synonyms
  • Probenecid
  • Probenecid acid
  • Probenecide
  • Probenecida
  • p-(Dipropylsulfamoyl)benzoic acid
Brand Names
  • Benuryl
  • Probenecid
  • Pro Biosan Kit
  • Benemid Tab 500mg
  • Probenecid and Colchicine
IndicationFor the reduction of serum uric acid concentrations in chronic gouty arthritis and tophaceous gout in patients with frequent disabling gout attacks. Has also been effectively used to promote uric acid excretion in hyperuricemia secondary to the administration of thiazide and related diuretics.
Categories
  • Adjuvants, Pharmaceutic
  • Amides
  • Antigout Preparations
  • Antirheumatic Agents
  • Compounds used in a research, industrial, or household setting
ATC-Code
  • M04AB01
  • G01AE10
  • M04AC51
CAS number57-66-9

Drug Targets

NameTarget SequencePharmacological ActionActions
Solute carrier family 22 member 6MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...unknowninhibitor
Solute carrier family 22 member 11MAFSKLLEQAGGVGLFQTLQVLTFILPCLMIPSQMLLENFSAAIPGHRCW...unknowninhibitor
Organic anion transporter 3MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCR...unknowninhibitor
Pannexin-1MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLI...unknownantagonist
Taste receptor type 2 member 16MIPIQLTVFFMIIYVLESLTIIVQSSLIVAVLGREWLQVRRLMPVDMILI...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL897
PubChem 4911
ChEMBL CHEMBL897
ChEBI CHEBI:8426
CCDC/CSD KANBOT, QQQBSS02, JIGKES03, JIGKES01, KANBIN01, QQQBSS03, JIGKES, JIGKES02, KANBUZ
COD 7119736, 7119737